Ursodeoxycholic acid induced generalized fixed drug eruption

Cutan Ocul Toxicol. 2014 Sep;33(3):256-8. doi: 10.3109/15569527.2013.838253. Epub 2013 Oct 22.


Fixed drug eruption (FDE) is a rare form of drug allergies that recur at the same cutaneous or mucosal site in every usage of drug. Single or multiple round, sharply demarcated and dusky red plaques appear soon after drug exposure. Ursodeoxycholic acid (UDCA: 3α,7β-dihydroxy-5β-cholanic acid) is used for the treatment of cholestatic liver diseases. Some side effects may be observed, such as diarrhea, dyspepsia, pruritus and headaches. We encountered only three cases of lichenoid reaction regarding the use of UDCA among previous studies. In this article, we reported a generalized FDE case related to UDCA intake in a 59-year-old male patient with cholestasis for the first time in the literature.

Keywords: Bile acids; generalized fixed drug eruption; ursodeoxycholic acid.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Cetirizine / therapeutic use
  • Cholestasis / drug therapy
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Gallstones / drug therapy
  • Histamine H1 Antagonists, Non-Sedating / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Mometasone Furoate
  • Pregnadienediols / therapeutic use
  • Skin / pathology
  • Ursodeoxycholic Acid / adverse effects*


  • Anti-Inflammatory Agents
  • Histamine H1 Antagonists, Non-Sedating
  • Pregnadienediols
  • Mometasone Furoate
  • levocetirizine
  • Ursodeoxycholic Acid
  • Cetirizine